INS and Hypoglycemia: Adding to the quagmire is the use of insulin in type 2 diabetics who fast during Ramadan, because of the increase risk of hypoglycemia compared with oral agents.43,44 Similar to the strategy used in oral hypoglycemic agents, most studies in this review switched their patients to an intermediate acting insulin preparation, which has a lower propensity to cause hypoglycemia.